Please login to the form below

Not currently logged in
Email:
Password:

companion diagnostics

This page shows the latest companion diagnostics news and features for those working in and with pharma, biotech and healthcare.

Edging Evolution

Edging Evolution

Value created beyond the pill, such as companion diagnostics and devices, are good examples of environmental selection, while me-too products that are not granted market access illustrate the market disfavouring

Latest news

More from news
Approximately 3 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    Diagnostics and cracking the market access code. For many of the company’s new generation of treatments, the uptake of companion diagnostics into routine clinical practice is another part of the ... Reic said the adoption of diagnostics into standard

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    The response has been a surge of interest in developing novel companion biomarkers, and biomarkers that allow personalisation of therapy. ... FDA is stimulating this approach and one can see the development of, for instance, TMB assays, targeted gene

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    9. RUTH MARCH. Precision medicine leader. Precision medicine and the use of companion diagnostics now plays a fully integrated role in many successful new cancer therapies. ... But how do you deliver these companion diagnostics to healthcare systems and

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    This encompasses approaches to detecting cancers earlier, including novel techniques such as liquid biopsies (aka circulating tumour DNA tests) and new companion diagnostics.

  • Breakthrough innovation Breakthrough innovation

    The same key agile principles with a different twist. Many pharmaceutical companies are increasingly looking to innovate through the development of companion diagnostics and drug delivery devices, and/or services such ... An optimal innovation approach.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

  • Dr Holger Adelmann joins DIA EMEA Dr Holger Adelmann joins DIA EMEA

    In that role he oversaw the reengineering of its clinical biomarker and companion diagnostics business to align with upcoming portfolio demands.

  • FlowMetric Diagnostics names president FlowMetric Diagnostics names president

    FlowMetric Diagnostics, a provider of flow cytometry and cell sorting services, has appointed Amy Williams as its president. ... It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised

  • Roche appoints new oncology research head Roche appoints new oncology research head

    Commenting on Pao's appointment, Reed said: "William is recognised as one of the world's leading molecular oncologists, with world class expertise in targeted cancer therapeutics, translational medicine, molecular diagnostics, ... diagnostics company,

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    Novartis and Roche are two champions of personalised medicine, shaping the area with the launch of targeted treatments combined with a companion diagnostic to support patient identification. ... approval of their new  FoundationOne CDx, the first and

  • Excellence in oncology: Developing an effective biomarker strategy

    Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients.

  • Research Partnership

    Medical devices and diagnostics. Our experience covers everything from insulin pens to large-scale surgical systems. ... Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics